150 related articles for article (PubMed ID: 23597199)
1. Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms.
Li X; Chen T; Lin S; Zhao J; Chen P; Ba Q; Guo H; Liu Y; Li J; Chu R; Shan L; Zhang W; Wang H
Curr Cancer Drug Targets; 2013 May; 13(4):472-83. PubMed ID: 23597199
[TBL] [Abstract][Full Text] [Related]
2. Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling.
Chen L; Feng D; Qian Y; Cheng X; Song H; Qian Y; Zhang X; Wu Y; Lv H; Liu Q; Cheng G; Yang B; Gu M
Phytomedicine; 2021 May; 85():153537. PubMed ID: 33744595
[TBL] [Abstract][Full Text] [Related]
3. Valtrate from
Tian S; Wang Z; Wu Z; Wei Y; Yang B; Lou S
Nat Prod Res; 2020 Sep; 34(18):2660-2663. PubMed ID: 30638055
[TBL] [Abstract][Full Text] [Related]
4. Jatamanvaltrate P induces cell cycle arrest, apoptosis and autophagy in human breast cancer cells in vitro and in vivo.
Yang B; Zhu R; Tian S; Wang Y; Lou S; Zhao H
Biomed Pharmacother; 2017 May; 89():1027-1036. PubMed ID: 28292011
[TBL] [Abstract][Full Text] [Related]
5. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
[TBL] [Abstract][Full Text] [Related]
6. Iridoids from Valeriana jatamansi with anti-inflammatory and antiproliferative properties.
Liu H; Liu D; Jiang MY; Zhao XD; Li RT; Li HM
Phytochemistry; 2021 Apr; 184():112681. PubMed ID: 33548771
[TBL] [Abstract][Full Text] [Related]
7. A new iridoid tetraester from Valeriana jatamansi.
Yu LL; Han CR; Huang R; Lv YP; Gui SH; Chen YG
Pharmazie; 2006 May; 61(5):486-8. PubMed ID: 16724553
[TBL] [Abstract][Full Text] [Related]
8. A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.
Jia L; Jin H; Zhou J; Chen L; Lu Y; Ming Y; Yu Y
BMC Complement Altern Med; 2013 Feb; 13():33. PubMed ID: 23410205
[TBL] [Abstract][Full Text] [Related]
9. Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway.
Liu X; Hu Y; Xue Z; Zhang X; Liu X; Liu G; Wen M; Chen A; Huang B; Li X; Yang N; Wang J
J Transl Med; 2023 Feb; 21(1):147. PubMed ID: 36829235
[TBL] [Abstract][Full Text] [Related]
10. F3, a novel active fraction of Valeriana jatamansi Jones induces cell death via DNA damage in human breast cancer cells.
Zhu Z; Shen W; Tian S; Yang B; Zhao H
Phytomedicine; 2019 Apr; 57():245-254. PubMed ID: 30797986
[TBL] [Abstract][Full Text] [Related]
11. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
12. Cleistopholine isolated from Enicosanthellum pulchrum exhibits apoptogenic properties in human ovarian cancer cells.
Nordin N; Majid NA; Mohan S; Dehghan F; Karimian H; Rahman MA; Ali HM; Hashim NM
Phytomedicine; 2016 Apr; 23(4):406-16. PubMed ID: 27002411
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
14. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
[TBL] [Abstract][Full Text] [Related]
15. Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.
Kaluzki I; Hrgovic I; Hailemariam-Jahn T; Doll M; Kleemann J; Valesky EM; Kippenberger S; Kaufmann R; Zoeller N; Meissner M
Tumour Biol; 2016 Oct; 37(10):13627-13635. PubMed ID: 27468725
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
[TBL] [Abstract][Full Text] [Related]
18. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.
Bae SN; Lee YS; Kim MY; Kim JD; Park LO
Gynecol Oncol; 2006 Oct; 103(1):127-36. PubMed ID: 16624386
[TBL] [Abstract][Full Text] [Related]
20. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
